Evidence map›Paper›PMID 29284484›Full record

ArticleBMC medical genomics2017

Platform-independent gene expression signature differentiates sessile serrated adenomas/polyps and hyperplastic polyps of the colon.

Yasir Rahmatallah, Magomed Khaidakov, Keith K Lai, Hannah E Goyne, Laura W Lamps, Curt H Hagedorn, Galina Glazko

Open access · goldAbstract read
In one paragraph

Article in BMC medical genomics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Yasir RahmatallahDepartment of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
Magomed KhaidakovThe Central Arkansas Veterans Healthcare System, Little Rock, AR, 72205, USA.
Keith K LaiDepartment of Anatomic Pathology, Cleveland Clinic, Cleveland, OH, 44195, USA.
Hannah E GoyneDepartment of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
Laura W LampsDepartment of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
Curt H HagedornThe Central Arkansas Veterans Healthcare System, Little Rock, AR, 72205, USA.
Galina GlazkoDepartment of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA. gvglazko@uams.edu.ORCID 0000-0002-0570-5304
University of Arkansas for Medical Sciences · USCentral Arkansas Veterans Healthcare System · USCleveland Clinic · USUniversity of Arkansas Medical Center · US

Funding

Understanding Hesitant AdoptersP20GM103429 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI Lawrence E Cornett, JERRY WARE · 2012 to 2026
$60.9M
Translational Regulation in Normal Erythropoiesis and Diamond Blackfan AnemiaP20GM121293 · NIGMS · ARKANSAS CHILDREN'S HOSPITAL RES INST · PI Samrat Roy Choudhury · 2017 to 2026
$27.6M
Arkansas Center for Clinical and Translational ResearchUL1TR000039 · NCATS · UNIV OF ARKANSAS FOR MED SCIS · PI BECK, CORNELIA MARIE, JAMES, LAURA P · 2012 to 2014
$10.0M
Molecular Phenotype of Polyps in Serrated Polyposis SyndromeR21CA176130 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI HAGEDORN, CURT H. · 2013 to 2014
$350k
Sentinel Pol II RNAs for Measuring RNA Integrity in BiospecimensR21CA148068 · NCI · UNIVERSITY OF UTAH · PI HAGEDORN, CURT H. · 2011 to 2012
$343k
National Science Foundation CRI CNS-0855248National Science Foundation EPS-0701890National Science Foundation MRI CNS-0619069National Science Foundation OISE-0729792NCATS NIH HHS UL1 TR000039NCI NIH HHS R21 CA148068NCI NIH HHS R21 CA176130NIGMS NIH HHS P20 GM103429NIGMS NIH HHS P20GM103429NIGMS NIH HHS P20 GM121293NIH Center of Biomedical Research Excellence P20GM121293NIH HHS CA148068NIH HHS CA176130NIH HHS UL1TR000039
6 · The paper itself

Abstract

backgroundSessile serrated adenomas/polyps are distinguished from hyperplastic colonic polyps subjectively by their endoscopic appearance and histological morphology. However, hyperplastic and sessile serrated polyps can have overlapping morphological features resulting in sessile serrated polyps diagnosed as hyperplastic. While sessile serrated polyps can progress into colon cancer, hyperplastic polyps have virtually no risk for colon cancer. Objective measures, differentiating these types of polyps would improve cancer prevention and treatment outcome.

methodsRNA-seq training data set and Affimetrix, Illumina testing data sets were obtained from Gene Expression Omnibus (GEO). RNA-seq single-end reads were filtered with FastX toolkit. Read mapping to the human genome, gene abundance estimation, and differential expression analysis were performed with Tophat-Cufflinks pipeline. Background correction, normalization, and probe summarization steps for Affimetrix arrays were performed using the robust multi-array method (RMA). For Illumina arrays, log

resultsThe classifier trained on RNA-seq data and tested on two independent microarray data sets resulted in zero and three errors. The classifier was further tested using quantitative real-time PCR expression levels of 45 blinded independent formalin-fixed paraffin-embedded specimens and was highly accurate. Pathway analyses have shown that sessile serrated polyps are distinguished from hyperplastic polyps and normal controls by: up-regulation of pathways implicated in proliferation, inflammation, cell-cell adhesion and down-regulation of serine threonine kinase signaling pathway; differential co-expression of pathways regulating cell division, protein trafficking and kinase activities.

conclusionsMost of the differentially expressed pathways are known as hallmarks of cancer and likely to explain why sessile serrated polyps are more prone to neoplastic transformation than hyperplastic. The new molecular classifier includes 13 genes and may facilitate objective differentiation between two polyps.

Indexed as

TranscriptomeAdenomaAlgorithmsCalcium-Calmodulin-Dependent Protein KinasesCell Cycle ProteinsCluster AnalysisColonic NeoplasmsColonic PolypsDatabases, GeneticDown-RegulationGene Regulatory NetworksGTP-Binding ProteinsHumansHyperplasiaIntracellular Signaling Peptides and ProteinsNeoplasm ProteinsCalcium-Calmodulin-Dependent Protein KinasesCell Cycle ProteinsCHFR protein, humanGBP2 protein, humanGTP-Binding ProteinsIntracellular Signaling Peptides and ProteinsNeoplasm ProteinsPoly-ADP-Ribose Binding ProteinsTRIB2 protein, humanUbiquitin-Protein LigasesCantelli’s inequalityFeature selectionFormalin-fixed paraffin-embeddedHyperplastic polypsMicroarraysMolecular signatureRNA-seqSessile serrated adenoma/polysShrunken centroid classifierSummary metric

Identifiers

PMID29284484
PMCPMC5745747
OpenAlexW2779874807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.